Official Full Name
poly (ADP-ribose) polymerase family, member 16
Poly (ADP-ribose) polymerase (PARP) catalyzes the post-translational modification of proteins by theaddition of multiple ADP-ribose moieties. PARP transfers ADP-ribose from nicotinamide dinucleotide (NAD) toglu/asp residues on the substrate protein, and also polymerizes ADP-ribose to form long/branched chainpolymers. PARP inhibitors are being developed for use in a number of pathologies including cancer, diabetes,stroke and cardiovascular disease.
PARP16; poly (ADP-ribose) polymerase family, member 16; C15orf30, chromosome 15 open reading frame 30; poly [ADP-ribose] polymerase 16; FLJ20509; FLJ25281; pART15; C15orf30; Chromosome 15 open reading frame 30; EC 126.96.36.199; PAR16_HUMAN; PARP 16; PARP-16; Poly (ADP ribose) polymerase family member 16; Poly [ADP ribose] polymerase 16; ARTD15, pART15, C15orf30; zgc:77744; mono [ADP-ribose] polymerase PARP16